These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6508977)

  • 1. Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.
    Taylor WB; Proctor SJ; Bateman DN
    Br J Clin Pharmacol; 1984 Nov; 18(5):679-84. PubMed ID: 6508977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
    Joss RA; Galeazzi RL; Brunner KW
    Eur J Clin Pharmacol; 1983; 25(1):35-9. PubMed ID: 6617723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of high-dose metoclopramide.
    Taylor WB; Bateman DN
    Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy.
    Taylor WB; Simpson JM; Bateman DN
    Eur J Clin Pharmacol; 1987; 33(2):161-5. PubMed ID: 3319642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
    Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiemetic inefficacy of high intravenous doses of metoclopramide by short-term infusion in vomiting induced by antineoplastic chemotherapy].
    Martín Jiménez M; González Larriba JL; Sangro B; Díaz-Rubio E
    Med Clin (Barc); 1986 Jun; 87(5):215-6. PubMed ID: 3736254
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens.
    Havsteen H; Nielsen H; Kjaer M
    Eur J Clin Pharmacol; 1986; 31(1):33-40. PubMed ID: 3780824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
    Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
    Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of high dose metoclopramide in patients with neoplastic disease.
    Bryson SM; McGovern EM; Kelman AW; White K; Addis GJ; Whiting B
    Br J Clin Pharmacol; 1985 Jun; 19(6):757-66. PubMed ID: 4027119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
    Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
    Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study.
    Gez E; Warner-Efraty E; Ben-Yosef R; Ben-Baruch N; Yitzhaki N; Uziely B; Brufman G; Biran S
    Oncology; 1987; 44(4):237-9. PubMed ID: 3614813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.
    Allen JC; Gralla R; Reilly L; Kellick M; Young C
    J Clin Oncol; 1985 Aug; 3(8):1136-41. PubMed ID: 4020411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
    Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B
    Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM
    J Clin Oncol; 1989 Jul; 7(7):943-6. PubMed ID: 2544688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL
    Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.